Accutome Revenue and Competitors
Estimated Revenue & Valuation
- Accutome's estimated annual revenue is currently $15.8M per year.
- Accutome's estimated revenue per employee is $251,000
Employee Data
- Accutome has 63 Employees.
- Accutome grew their employee count by -22% last year.
Accutome's People
| Name | Title | Email/Phone |
|---|
Accutome Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $92.4M | 368 | 26% | N/A | N/A |
#2 | $7M | 28 | 0% | N/A | N/A |
#3 | $46.2M | 184 | 13% | N/A | N/A |
#4 | $2.6M | 21 | -78% | $64.3M | N/A |
#5 | $10.8M | 43 | 16% | N/A | N/A |
#6 | $46.4M | 148 | -17% | N/A | N/A |
#7 | $26.1M | 104 | 18% | N/A | N/A |
#8 | $26.9M | 107 | 8% | N/A | N/A |
#9 | $40.7M | 162 | 9% | N/A | N/A |
#10 | $38.9M | 155 | 11% | N/A | N/A |
What Is Accutome?
Accutome Inc. now offers an immersion biometry training program. The company will send a service technician to your office to train your staff on the use of the AccuSonic A-Scan, including hands-on immersion training. Alternatively, Accutome will pay the tuition for one person to attend a hands-on CME-certified course on biometry with the purchase of the AccuSonic A-Scan. The company offers 30-day trials for its ultrasound equipment.
keywords:N/A
N/A
Total Funding
63
Number of Employees
$15.8M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Accutome News
Allergan, Accutome, Prestige Brands, Bausch & Lomb, Croda, Akorn Consumer, Health, Shire, Scope Ophthalmics, VISUfarma, Novartis,...
... Scope, Top Players 2016 to 2028 | VEDENG, Storz, ASICO, Geuder, Accutome, Medline Industries, Ambler Surgical, BD, Millennium Surgical,
B-Scan Ocular Ultrasound Devices Market to Witness Growth Acceleration | Accutome (Halma plc), Quantel Medical, Ellex Medical Lasers.
Other Companies in Malvern
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14M | 65 | N/A | N/A |
#2 | $11.9M | 65 | 12% | N/A |
#3 | $14.6M | 65 | -11% | N/A |
#4 | $5.9M | 65 | -2% | N/A |
#5 | $13.3M | 67 | 43% | N/A |